title: Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma.
authors.affiliation: Department of Haematology, Hospital 12 de Octubre, Madrid, Spain.
authors.forename: Ana
authors.initials: A
authors.lastname: Rivero
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Rapado
authors.forename: José F
authors.initials: JF
authors.lastname: Tomás
authors.forename: Carlos
authors.initials: C
authors.lastname: Montalbán
authors.forename: Raquel
authors.initials: R
authors.lastname: de Oña
authors.forename: José
authors.initials: J
authors.lastname: Paz-Carreira
authors.forename: Miguel
authors.initials: M
authors.lastname: Canales
authors.forename: Rafael
authors.initials: R
authors.lastname: Martínez
authors.forename: Pedro
authors.initials: P
authors.lastname: Sánchez-Godoy
authors.forename: Alberto Fernández
authors.initials: AF
authors.lastname: de Sevilla
authors.forename: Javier
authors.initials: J
authors.lastname: de la Serna
authors.forename: Joaquín
authors.initials: J
authors.lastname: Martínez-López
mesh_terms: D000483:Alleles; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D003842:Deoxycytidine Kinase / Q000235:genetics*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000235:genetics; D015971:Gene Expression Regulation, Enzymologic; D015973:Gene Expression Regulation, Leukemic; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D053208:Kaplan-Meier Estimate; D016015:Logistic Models; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000235:genetics*; D008231:Lymphopenia / Q000139:chemically induced; D009503:Neutropenia / Q000139:chemically induced; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D003842:Deoxycytidine Kinase; D014740:Vidarabine; C024352:fludarabine